Related content

High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors

By Wendtner C.-M.   Kurzeder C.   Theiss H.D.   Kofler D.M.   Baumert J.   Delecluse H.-J.   Janz A.   Hammerschmidt W.   Hallek M.  

Experimental Hematology, Vol. 31, Iss. 2, 2003-02 ,pp. : 99-108

Elsevier

Access to resources Recommend Favorite

Influence of Epstein–Barr virus infection in adult T-cell leukemia

By Ueda Satomi   Maeda Yasuhiro   Yamaguchi Terufumi   Hanamoto Hitoshi   Hijikata Yasuki   Tanaka Miyako   Takai Shunsuke   Hirase Chikara   Morita Yasuyoshi   Kanamaru Akihisa  

Hematology, Vol. 13, Iss. 3, 2008-06 ,pp. : 154-162

Maney Publishing

Access to resources Recommend Favorite

Cytotoxic gammadelta T Lymphocytes Associated with an Epstein-Barr Virus-Induced Posttransplantation Lymphoproliferative Disorder

By Rothenberg M.E.   Weber W.E.J.   Longtine J.A.   Hafler D.A.  

Clinical Immunology, Vol. 80, Iss. 3, 1996-09 ,pp. : 266-272

Academic Press

Access to resources Recommend Favorite

Prospective study of Epstein-Barr virus chronic infection in renal transplant recipients

By Lauzurica R.   Frias C.   Bayes B.   Hernandez A.   Bonet J.   Arnal J.   Romero R.   Ausina V.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2339-2340

Elsevier

Access to resources Recommend Favorite

Novel therapies for chronic myelogenous leukemia

By Jahagirdar B.N.   Miller J.S.   Shet A.   Verfaillie C.M.  

Experimental Hematology, Vol. 29, Iss. 5, 2001-05 ,pp. : 543-556

Elsevier

Access to resources Recommend Favorite